Physician profile
John Wallace
NPI 1225292634
$8,352.83
in general payments reported to CMS, 2019-2025
20 companies · $497 in 2025
The $497 reported for 2025 was more than what 91% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,334 · 2020: $2,284 · 2021: $612 · 2022: $737 · 2023: $1,125 · 2024: $763 · 2025: $497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,385.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,932.59 | 2019-2025 | Proclaim, Prodigy, Axium |
| Medtronic USA, INC. | $1,892.23 | 2019-2020 | |
| Nevro Corp. | $485.18 | 2019-2022 | |
| Medtronic, INC. | $372.65 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Inceptiv |
| Nalu Medical, INC. | $337.25 | 2021-2024 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $267.51 | 2024 | Prospera |
| Mml US, INC. | $196.82 | 2024 | Reactiv8 |
| Relievant Medsystems, INC. | $171.62 | 2019-2021 | |
| Corelink, LLC | $147.90 | 2023 | |
| Boston Scientific Corporation | $139.06 | 2025 | Intracept Rf Probe |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2019 | |
| Redhill Biopharma INC. | $72.24 | 2020-2021 | |
| Zyla Life Sciences, INC. | $40.86 | 2019 | |
| Nuvasive, INC. | $37.95 | 2020 | |
| Biodelivery Sciences International, INC. | $36.92 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $28.27 | 2023 | |
| Radius Health, INC. | $26.22 | 2024 | Tymlos |
| Daiichi Sankyo INC. | $18.42 | 2019 | |
| Depuy Synthes Sales INC. | $12.40 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.